Skip to main content

Cancer Genetics, Inc. (NASDAQ: CGIX) Investor Securities Class Action Lawsuit 04/05/2018

  • If you purchased shares of Cancer Genetics, Inc. (NASDAQ: CGIX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 25, 2020 - The court granted the defendants' motion to dismiss. The case was dismissed with prejudice. December 31, 2018 - A motion to dismiss the amended complaint was filed. October 30, 2018 - An amended complaint was filed. April 5, 2018 - An investor in shares of Cancer Genetics, Inc. (NASDAQ: CGIX) filed a lawsuit in the U.S. District Court for the District of New Jer...



You must register (for free) or login to view the entire case.